Fed's Goolsbee said the US has not yet experienced a stagflation shock and the labor market has remained stable.

Canada core CPI YoY May 2.2% (prev 2.1%).

China's National Medical Products Administration granted priority-review approval to Kaixing Life Sciences (Shanghai) Co. for Shurui Jiaolunsai injection, marketed as Kailimei, for CLDN18.2‑positive, HER2‑negative advanced gastric or gastroesophageal junction adenocarcinoma in patients who have progressed after at least two prior lines of therapy. The approval adds a new later‑line treatment option for this biomarker‑defined patient population.